Restricted accessResearch articleFirst published online 2008-7
Mortality of the elderly is still exceedingly high at diagnosis of AIDS despite favourable outcomes after highly active antiretroviral therapy in Recife,Brazil
This study aimed to compare the outcome of an elderly group of AIDS patients with that of a younger group and their features at the time of the diagnosis of AIDS. We evaluated 58 patients aged >60 years and 114 aged 20–39 years, followed for 35.3 months. There was an obvious delay in diagnosing the elderly as they had more AIDS-defining diseases at diagnosis and their most frequent opportunistic infection was pulmonary tuberculosis. Mortality at the time of the diagnosis of AIDS was four times higher in the elderly (24.1% versus 6.1%, P < 0.001). However, when comparing only those submitted to highly active antiretroviral therapy, there was a similar frequency of favourable outcomes; 76.9% in the elderly against 83.1% in the young (P = 0.455). Mean CD4 lymphocyte was 438 cells/mm3 at the end of follow up in the young when compared with 442 cells/mm3 in the elderly (P = 0.945). The types of antiretroviral schema and the number of antivirals per patient were similar in both groups.
Brazilian Ministry of Health. National program of STD and AIDs. Epidemiol Bull AIDS STD2007;1
2.
Centers for Disease Control and Prevention. AIDS among persons aged ≥50 years: United States, 1991–1996. Morb Mort Wkly Rep1998;47:21–7
3.
PeateI. Human immunodeficiency virus and the older person. Br J Nurs2007;16:606–10
4.
PalellaFJJr, DelaneyMS, MoormanAC, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med1998;338:853–60
5.
AuerbachJD. HIV/AIDS and aging: interventions for older adults. J Acquir Immun Defic Syndr2003;33:S57–8
6.
GordonSM, ThompsonS. The changing epidemiology of human immunodeficiency virus infection in older persons. J Am Geriatr Soc1995;43:7–9
7.
Joint United Nations Programme on HIV/AIDS. Impact of AIDS on Older Populations. Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS Secretariat2002
8.
GrandonJD. HIV infection in the older population. Clin Geriatr2004;12:37–45
9.
ManfrediR. HIV disease and advanced age – an increasing therapeutic challenge. Drugs Aging2002;19:647–69
10.
KnobelH, GuelarA, ValldecilloG, CarmonaA, GonzalézA, López-ColomésJL. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS2001;15:1591–3
11.
TumbarelloM, RabagliatiR, DonatiKG, Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario. AIDS2003;17:128–31
12.
El-SadrW, WelterJ. Unrecognized human immunodeficiency virus infection in the elderly. Arch Int Med1995;155:184–6
13.
ChiaoEY, RiesKM, SandeMA. AIDS and the elderly. Clin Infect Dis1999;28:740–5
14.
ManfrediR, ChiodoF. A case-control study of virological anda immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS2000;14:1475–7
15.
GoetzMB, BoscardinWJ, DorothyW, AlasspoolesS. Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy. AIDS2001;15:1576–9
16.
Brazilian Institute of Geography and Statistics [http://www.ibge.gov.br/ibgeteen/datas/idoso/política_do_idoso_no_brasil.html]. (accessed on 8 November 2007)
17.
ZelenetzPD, EpsteinME. HIV in the elderly. AIDS Patient Care1998;12:255–62
18.
PerezJL, MooreRD. Greater effect of highly active antiretroviral therapy on survival in people aged ≥ 50 years compared with younger people in an urban observational cohort. Clin Infect Dis2003;36:212–8
19.
InunguJN, MokotoffED, KentJB. Characteristics of HIV Infection in patients fifty years or older in Michigan. AIDS Patient Care STDs2001;15:567–73
20.
SkiestDJ, RubinstienE, CarleyN, GioiellaL, LyonsR. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am J Med1996;101:605–11
21.
GrimesRM, OtinianoME, Rodriguez-BarradasMC, LaiD. Clinical experience with human immunodefficiency vírus-infected older patients in the era of effective antiretroviral therapy. Clin Infect Dis2002;34:1530–3
22.
MeloLSW, RamosH, XimenesRAA, CampeloEH, MoraesEF. Sobrevida dos pacientes com Aids e características dos que evoluíram para óbito, em oito anos de terapia anti-retroviral potente numa unidade de referência do Nordeste, Brasil. Brazil J Infect Dis2007;11:S20
23.
NoguerasM, NavarroG, AntónE, Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. BMC Infect Dis2006;6:159
24.
TumbarelloM, RabagliatiR, DonatiKG, Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active anti retroviral therapy. BMC Infect Dis2004;4:46–56
25.
RaviglioneMC, SniderDE, KochiA. Global epidemiology of tuberculosis morbidity and mortality of a worldwide epidemic. JAMA1995;273:220–6
26.
ViardJ, MocroftA, ChiesiA, EuroSIDA Study Group. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis2001;183:1290–4
27.
ChidgeyA, DudakovJ, SeachN, BoydR. Impact of niche aging on thimic regeneration and immune reconstitution. Semin Immunol2007;19:331–40
28.
SaltzmanRI, PetersonPK. Immunodeficiency of the elderly. Rev Infect Dis1987;9:1127–9
29.
GrabarS, KousignianI, SobelA, Immunological and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS2004;18:2029–38
